Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

ClinicalTrials.gov ID: NCT03257033

Public ClinicalTrials.gov record NCT03257033. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine Plus Nab-Paclitaxel Following Induction With Sequential IV Gemcitabine Plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.

Study identification

NCT ID
NCT03257033
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
RenovoRx
Industry
Enrollment
190 participants

Conditions and interventions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2018
Primary completion
May 31, 2027
Completion
Aug 31, 2027
Last update posted
Aug 23, 2026

2018 – 2027

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
35
Facility City State ZIP Site status
VA Loma Linda Healthcare System Loma Linda California 92357 Terminated
Sutter Cancer Center Sacramento Sacramento California 95816 Recruiting
Rocky Mountain Cancer Centers Denver Colorado 80218 Withdrawn
Comprehensive Cancer Care and Research Institute of Colorado, CCCRIC Englewood Colorado 80113 Withdrawn
Sibley Memorial Hospital - a member of Johns Hopkins medicine Washington D.C. District of Columbia 20016 Recruiting
Georgetown University Washington D.C. District of Columbia 20057 Withdrawn
21st Century Oncology Fort Myers Florida 33907 Terminated
Miami Cancer Center Miami Florida 33167 Recruiting
Sarasota Memorial Health Care System Sarasota Florida 34329 Recruiting
Moffitt Cancer Center Tampa Florida 33612 Terminated
ASCLEPES Research Centers Weeki Wachee Florida 34607 Terminated
Piedmont-Columbus Regional - John B. Amos Cancer Center Columbus Georgia 31904 Withdrawn
University of Iowa Hospitals and Clinics - Holden Comprehensive Cancer Center Iowa City Iowa 52242 Recruiting
Ochsner Clinic Foundation New Orleans Louisiana 70121 Withdrawn
LSU Health Shreveport Shreveport Louisiana 71103 Withdrawn
Medstar Franklin Square Baltimore Maryland 21237 Terminated
University of Nebraska Medical Center Omaha Nebraska 68198 Recruiting
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766 Terminated
MD Anderson Cancer Center at Cooper Hospital Camden New Jersey 08103 Terminated
Atlantic Health System - Morristown Medical Center Morristown New Jersey 07960 Withdrawn
Albany Stratton VA Medical Center Albany New York 12208 Withdrawn
Feinstein Institutes for Medical Research - Northwell Health Manhasset New York 11030 Recruiting
Columbia University Medical Center New York New York 10032 Terminated
Montefiore Hospital The Bronx New York 10461 Terminated
Levine Cancer Institute - Atrium Health Charlotte North Carolina 28204 Recruiting
East Carolina University Greenville North Carolina 27834 Recruiting
Wake Forest Baptist Comprehensive Cancer Center Winston-Salem North Carolina 27157 Active, not recruiting
Oklahoma University - Stephenson Cancer Center Oklahoma City Oklahoma 73104 Recruiting
Oregon Health & Science University Portland Oregon 97239 Recruiting
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 Recruiting
Medical University of South Carolina - Hollings Cancer Center Charleston South Carolina 29425 Active, not recruiting
Prisma Health (formerly Greenville Health System) Greenville South Carolina 29605 Recruiting
Sarah Cannon Research Institute Nashville Tennessee 37203 Withdrawn
University of Texas Southwestern Medical Center Dallas Texas 75390 Recruiting
VA Puget Sound Health Care System Seattle Washington 98108 Withdrawn
West Virginia University Medicine Morgantown West Virginia 26506 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03257033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03257033 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →